ARTICLE | Management Tracks
Protego names Warner CEO
Plus: Foghorn hires Humer and updates from Javelin, Stoke, Sensorium, Theradaptive and more
April 18, 2024 12:52 AM UTC
Brent Warner announced on LinkedIn that he has joined Protego Biopharma Inc., which is targeting misfolded protein diseases, as CEO. Warner was president of Poseida Therapeutics Inc. (NASDAQ:PSTX).
Foghorn Therapeutics Inc. (NASDAQ:FHTX) hired Kristian Humer as CFO. Humer was CFO and CBO at Viridian Therapeutics Inc. (NASDAQ:VRDN). Foghorn is targeting genetically determined dependencies within the chromatin regulatory system...